Site‐specific microRNA‐33 antagonism by pH‐responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity

C Li, Y Dou, Y Chen, Y Qi, L Li, S Han… - Advanced functional …, 2020 - Wiley Online Library
Atherosclerosis remains the leading cause of a broad spectrum of deadliest cardiovascular
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …
被引用次数：75 相关文章

Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity.

C Li, Y Dou, Y Chen, Y Qi, L Li, S Han… - Advanced …, 2020 - search.ebscohost.com
Atherosclerosis remains the leading cause of a broad spectrum of deadliest cardiovascular
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …

[引用][C] Site-Specific MicroRNA-33 Antagonism by pH-Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive …

C Li, Y Dou, Y Chen, Y Qi, L Li, S Han, T Jin… - Advanced Functional …, 2020 - hero.epa.gov
Site-Specific MicroRNA-33 Antagonism by pH-Responsive Nanotherapies for Treatment of
Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity | Health & …